QStat Cartridge
Hemostasis assessment for peripartum obstetric procedures
CommercialActive
Key Facts
Indication
Hemostasis assessment for peripartum obstetric procedures
Phase
Commercial
Status
Active
Company
About HemoSonics
HemoSonics is a private, commercial-stage diagnostics company focused on revolutionizing bleeding management through its proprietary Quantra® System. The platform utilizes a patented ultrasound-based technology called SEER Sonorheometry to deliver rapid, accurate viscoelastic test results at the point-of-care or in the lab. The company targets high-acuity hospital settings where timely hemostasis assessment is critical, with a clear value proposition in reducing transfusion volumes, hospital length of stay, and overall care costs. HemoSonics has achieved significant regulatory milestones, including FDA clearance for use in peripartum obstetric procedures.
View full company profile